- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2009
- Public Summary Document (PSD) November 2009 PBAC Meeting - PDF
Ustekinumab (rmc) – November 2009
Ustekinumab (rmc), solution for injection, 45 mg in 0.5 mL, Stelara®, November 2009
Last updated
5 March 2010